SOMATOSTATINOMA

Clinical trials for SOMATOSTATINOMA explained in plain language.

Never miss a new study

Get alerted when new SOMATOSTATINOMA trials appear

Sign up with your email to follow new studies for SOMATOSTATINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for rare pancreatic tumors: Two-Drug combo shows promise

Disease control Ongoing

This study tested two chemotherapy drugs—temozolomide alone or combined with capecitabine—in 144 people with advanced pancreatic neuroendocrine tumors that could not be removed by surgery. The goal was to see if the combination could delay tumor growth better than the single drug…

Matched conditions: SOMATOSTATINOMA

Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control

Last updated May 09, 2026 06:48 UTC

SOMATOSTATINOMA

Get alerted when new SOMATOSTATINOMA trials appear

New hope for rare pancreatic tumors: Two-Drug combo shows promise